Circulating Tumor Cells Are A Reliable Predictor Of Treatment Response In Metastatic Breast Cancer
With the goal of tailoring cancer treatment for each individual, researchers at Georgetown University Medical Center have presented a study suggesting a simple blood test can help doctors more reliably assess treatment efficacy for patients with metastatic breast cancer.
More: continued here
Filed under: Breast Cancer on May 18th, 2008